{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:05:47Z","timestamp":1792699547589,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NP\/B166-174"],"award-info":[{"award-number":["NP\/B166-174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["AI059374"],"award-info":[{"award-number":["AI059374"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102594","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:31:04Z","timestamp":1749497464000},"page":"102594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets"],"prefix":"10.1016","volume":"36","author":[{"given":"Wen-Chien","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy E.","family":"Sayedahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elkashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralimanohara S.T.","family":"Murala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-8449","authenticated-orcid":false,"given":"Suresh K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102594_bib1","series-title":"Influenza (Seasonal)","year":"2023"},{"key":"10.1016\/j.omtn.2025.102594_bib2","article-title":"Progress towards the Development of a Universal Influenza Vaccine","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102594_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102594_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14760584.2017.1379396","article-title":"Vaccine approaches conferring cross-protection against influenza viruses","volume":"16","author":"Vemula","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2025.102594_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-018-0340-z","article-title":"Current and future influenza vaccines","volume":"25","author":"Yamayoshi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib6","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","article-title":"A universal dual mechanism immunotherapy for the treatment of influenza virus infections","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.abg6302","article-title":"Emerging H5N8 avian influenza viruses","volume":"372","author":"Shi","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102594_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102594_bib9","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2666-5247(22)00232-4","article-title":"The time is now: a call to contain H9N2 avian influenza viruses","volume":"3","author":"Bi","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.omtn.2025.102594_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1126\/science.adp6024","article-title":"Worries about bird flu in U.S. cattle intensify","volume":"384","author":"Cohen","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102594_bib11","article-title":"Development of NP-Based Universal Vaccine for Influenza A Viruses","volume":"12","author":"Sayedahmed","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2025.102594_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","article-title":"Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102594_bib13","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102594_bib15","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1038\/s41467-019-13346-4","article-title":"Challenging immunodominance of influenza-specific CD8(+) T cell responses restricted by the risk-associated HLA-A\u221768:01 allomorph","volume":"10","author":"van de Sandt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib16","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/ncomms3663","article-title":"Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides","volume":"4","author":"Valkenburg","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib17","first-page":"818","article-title":"Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102594_bib18","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41467-024-47590-0","article-title":"Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children","volume":"15","author":"Jia","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/imcb.12508","article-title":"Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence","volume":"100","author":"Vanderven","year":"2022","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102594_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2161","article-title":"Unveiling the roles of autophagy in innate and adaptive immunity","volume":"7","author":"Levine","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2025.102594_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1104904","article-title":"Endogenous MHC class II processing of a viral nuclear antigen after autophagy","volume":"307","author":"Paludan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102594_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.immuni.2007.07.004","article-title":"Innate and adaptive immunity through autophagy","volume":"27","author":"Schmid","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2025.102594_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.1720","article-title":"Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection","volume":"10","author":"English","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2025.102594_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102594_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.omtm.2023.06.009","article-title":"Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine","volume":"30","author":"Sayedahmed","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102594_bib27","article-title":"A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice","volume":"2","author":"Khan","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib28","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1128\/JVI.73.11.9137-9144.1999","article-title":"Replication-defective bovine adenovirus type 3 as an expression vector","volume":"73","author":"Reddy","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102594_bib29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2008.12","article-title":"Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus","volume":"16","author":"Singh","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102594_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.omtm.2018.07.007","article-title":"A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose","volume":"10","author":"Sayedahmed","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102594_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2009.01.008","article-title":"Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model","volume":"386","author":"Sharma","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102594_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virusres.2010.07.021","article-title":"Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model","volume":"153","author":"Sharma","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2025.102594_bib33","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1128\/JVI.76.12.5882-5892.2002","article-title":"Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted","volume":"76","author":"van Olphen","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102594_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/MMBR.00022-16","article-title":"Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models","volume":"80","author":"Belser","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.omtn.2025.102594_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.meegid.2016.03.010","article-title":"Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus","volume":"40","author":"Zhang","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.omtn.2025.102594_bib36","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102594_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3201\/eid3007.240508","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024","volume":"30","author":"Burrough","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102594_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib40","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiz003","article-title":"The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines","volume":"219","author":"Saelens","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102594_bib41","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S1473-3099(23)00351-1","article-title":"Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"23","author":"Leroux-Roels","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102594_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14760584.2019.1578216","article-title":"Immunological basis for enhanced immunity of nanoparticle vaccines","volume":"18","author":"Kelly","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2025.102594_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102594_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.medj.2021.12.005","article-title":"Durability of immune responses to the BNT162b2 mRNA vaccine","volume":"3","author":"Suthar","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.omtn.2025.102594_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1345","article-title":"Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections","volume":"10","author":"Elkashif","year":"2021","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.omtn.2025.102594_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102594_bib47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102594_bib48","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtn.2025.102594_bib49","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/14712590903307388","article-title":"Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors","volume":"9","author":"Seregin","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2025.102594_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102594_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102594_bib52","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101591","article-title":"Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial","volume":"9","author":"Hayton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102594_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2025.102594_bib55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7861\/clinmed.2022-0006","article-title":"The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Toh","year":"2022","journal-title":"Clin. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib57","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s11739-021-02793-x","article-title":"Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines","volume":"16","author":"Marcucci","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib58","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102594_bib59","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102594_bib60","article-title":"Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses","volume":"13","author":"Wang","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2025.102594_bib61","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3389\/fimmu.2019.02005","article-title":"Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge","volume":"10","author":"McMahon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102594_bib62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-019-1991-3","article-title":"Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice","volume":"17","author":"Joe","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib63","doi-asserted-by":"crossref","first-page":"e02359-20","DOI":"10.1128\/JVI.02359-20","article-title":"Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model","volume":"95","author":"Dhakal","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102594_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.01.002","article-title":"Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus","volume":"163","author":"Kim","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2025.102594_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virusres.2011.09.031","article-title":"Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer","volume":"163","author":"Tandon","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2025.102594_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.virol.2009.06.029","article-title":"Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry","volume":"392","author":"Li","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102594_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102594_bib68","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/s41467-018-07815-5","article-title":"Broad CD8(+) T cell cross-recognition of distinct influenza A strains in humans","volume":"9","author":"Grant","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102594_bib69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/icb.2012.78","article-title":"Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses","volume":"91","author":"Grant","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102594_bib70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-019-0122-8","article-title":"An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice","volume":"4","author":"Khan","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2025.102594_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00711-24","article-title":"The frequency and function of nucleoprotein-specific CD8(+) T cells are critical for heterosubtypic immunity against influenza virus infection","volume":"98","author":"Amoah","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102594_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027517","article-title":"Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract","volume":"7","author":"Jayaraman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102594_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajpath.2019.09.017","article-title":"A Guide for the Use of the Ferret Model for Influenza Virus Infection","volume":"190","author":"Belser","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102594_bib74","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature12391","article-title":"Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice","volume":"501","author":"Belser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102594_bib75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/vim.2009.0045","article-title":"Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus","volume":"22","author":"Kim","year":"2009","journal-title":"Viral Immunol."},{"key":"10.1016\/j.omtn.2025.102594_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-9065-8_9","article-title":"Current Use of Adenovirus Vectors and Their Production Methods","volume":"1937","author":"Sayedahmed","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102594_bib77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/348252a0","article-title":"Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells","volume":"348","author":"R\u00f6tzschke","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102594_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1386-6532(03)00122-7","article-title":"Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement","volume":"29","author":"Ward","year":"2004","journal-title":"J. Clin. Virol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:32:18Z","timestamp":1777321938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125001489"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102594","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102594"}}